|
|
7David R Sherman
![]() Summary for 2004 [at-glance overview of David R Sherman work for the selected year as suggested by data mining algorithms]This is an Authoratory overview of author David R Sherman. According to available data, in 2004 David R Sherman published at least 7 articles. This work was completed in collaboration with several authors including Behr, Marcel A and Smith, Sherilyn. Many other authors have collaborated with David R Sherman as well. At least 20 different grants are awarded to David R Sherman to support this work. All time total of the grant awards on file exceeds $18,617,318.
David R Sherman has rank 7 when compared to all other authors using the keyword BCG Vaccine. Analysis of the article abstracts and the titles suggests that David R Sherman professional interests are focused around "methoxymycolic acid production", "impact methoxymycolic acid" and "export esat-6 cfp-10". These might also be referred to as "mycobacterium tuberculosis", "methoxymycolic acid" or "bovis bcg". Statistical analysis shows that David R Sherman's writing is likely to contains terms "mycobacterium", "rd1", "tuberculosis", "bcg", "adenylylation" and "gs".
Unfortunately, there is not enough information to establish David R Sherman affiliation. Luckily, one email address is on file. Images [images we found on the Internet for David R Sherman]loading...
Do you know David R Sherman who matches the profile above? Click the photo and let us know!
Alternative names (0) [other authors with names similar to David R Sherman]Year 2004 Charts [David R Sherman frequent coauthors and the most common unique vocabulary terms for the selected year]Historical Performance Charts [graphical overview of David R Sherman publication and funding history for the range of years]Emails (1) [email addresses extracted from David R Sherman affiliations]hidden to prevent spam, click here to reveal David R Sherman Coauthors (18) [all coauthors with the number of joint publications] Other [context-specific ads]Affiliations (6) [condensed summary of the David R Sherman affiliations, the leading number and the color conveys importance]- 2Department of Pathobiology, University of Washington, Seattle 98195-7238, WA 98195, USA.
1Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USA. 1Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington 98195, USA. 1Centre for the Study of Host Resistance, McGill University, Montreal H3G 1A4, Canada. 1Departments of Pathobiology and Medicinal Chemistry, University of Washington, Seattle, Washington 98195-7610, USA. 1McGill University Health Centre, Montreal, Canada H3G 1A4.
Key Opinion Leader In [David R Sherman is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 7BCG Vaccine | 9Virulence | 20Mycobacterium tuberculosis | 24Genes, Bacterial | 303Phenotype | 588Bacterial Proteins
Keywords (32) [keywords assigned to David R Sherman articles by PubMed, the leading number and the color conveys importance]- 6Mycobacterium tuberculosis | 5Virulence | 4Mice | 4Genes, Bacterial | 4Animals | 3BCG Vaccine | 3Mice, Inbred C57BL | 3Humans | 3Bacterial Proteins | 3Phenotype | 3Mutation | 3Cell Line | 2Base Sequence | 2Mycobacterium bovis | 2DNA, Bacterial | 2Gene Deletion | 2Genetic Complementation Test | 2Macrophages | 2Time Factors | 2Oligonucleotide Array Sequence Analysis | 1Mutagenesis, Site-Directed | 1Mutagenesis | 1Gene Expression Regulation, Enzymologic | 1Nitric Oxide | 1Glutamate-Ammonia Ligase | 1Tuberculoma | 1Glutamine | 1Tuberculosis | 1Mycobacterium Infections | 1Species Specificity | 1Tuberculosis Vaccines | 1Tyrosine
David R Sherman Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; David R Sherman might be a good expert witness on these terms]- 21mycobacterium | 19rd1 | 18tuberculosis | 13bcg | 11adenylylation | 10gs | 10mtb | 8bovis | 7expression | 7strains | 7acid | 6h37rv | 6methoxymycolic | 6attenuated | 6macrophages | 6glutamine | 6mycobacteria | 5virulent | 5coli | 5results | 4bacteria | 4atase | 4dosr | 4demonstrate | 4required | 4adenylylated | 4region | 4vaccine | 4infection | 4may | 3catalytic | 3regulated
- 14mycobacterium tuberculosis | 5methoxymycolic acid | 5bovis bcg | 4acid production | 3bcg strains | 3coli atase | 3mtb gs | 3nitric oxide | 3impact methoxymycolic | 3tuberculosis h37rv | 3sensor kinases | 3escherichia coli | 3tuberculous granuloma | 3virulence determinant | 3granuloma formation | 2genetic complementation | 2export esat-6 | 2bovis bacille | 2synthetase expressed | 2response mycobacterium | 2bcg pasteur | 2rin long-term | 2cfp-10 virulence | 2kinases contribute | 2vitro vivo | 2genes required | 2calmette-gu rin | 2coli versus | 2adenylylation catalytic | 2contribute hypoxic | 2h37rv deltard1 | 2virulence mycobacterium
- 4methoxymycolic acid production | 3impact methoxymycolic acid | 2export esat-6 cfp-10 | 2low adenylylation states | 2esat-6 cfp-10 virulence | 2formation enhanced mycobacterium | 2long-term murine infection | 2response mycobacterium tuberculosis | 2required export esat-6 | 2calmette-gu rin long-term | 2coli versus mycobacteria | 2tuberculous granuloma formation | 2sensor kinases contribute | 2bacille calmette-gu rin | 2kinases contribute hypoxic | 2electrospray ionization mass | 2rin long-term murine | 2escherichia coli versus | 2catalytic properties mycobacterium | 2virulence mycobacterium tuberculosis | 2properties mycobacterium tuberculosis | 2enhanced mycobacterium virulence | 2genes required export | 2granuloma formation enhanced | 2adenylylation catalytic properties | 2expressed escherichia coli | 2rd1-region genes required | 2tuberculosis glutamine synthetase | 2cfp-10 virulence mycobacterium | 2glutamine synthetase expressed | 2hypoxic response mycobacterium | 2mycobacterium tuberculosis glutamine
Reader's Comments (0) [comments posted by readers of David R Sherman profile]Funding (20) [selected NIH grants to David R Sherman and the award amounts for recent years]- ANALOGING AND ANALYSIS OF ANTITUBERCULAR PHARMACOPHORES (SHERMAN, DAVID - 1998)
| Grant # | Award Year | Award Amount, USD | | 1R43AI042426-01 | 1998 | $100,000 | | Total up to 2004 | $100,000 |
- HYPOXIA, LATENCY AND REACTIVATION IN M.TUBERCULOSIS (SHERMAN, DAVID - 2002)
| Grant # | Award Year | Award Amount, USD | | 1R21AI047744-01A1 | 2001 | $321,549 | | 1R01AI047744-01A2 | 2002 | $166,635 | | 5R01AI047744-02 | 2003 | $348,757 | | 5R01AI047744-03 | 2004 | $351,008 | | Total up to 2004 | $1,187,949 |
- MOLECULAR BASIS FOR CYCLOSPORIN-A T-CELL SPECIFICITY (SHERMAN, DAVID - 1982)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- BIOCHEMISTRY AND MOLECULAR GENETICS OF MITOMYCIN BIOSYNT (SHERMAN, DAVID - 2000)
| Grant # | Award Year | Award Amount, USD | | 1R01CA081172-01A1 | 2000 | $302,523 | | 5R01CA081172-02 | 2001 | $287,909 | | 5R01CA081172-03 | 2002 | $296,548 | | 5R01CA081172-04 | 2003 | $305,444 | | Total up to 2004 | $1,192,424 |
- COMBINATORIAL CREATION OF NEW ANTICANCER AGENTS (SHERMAN, DAVID - 1999)
| Grant # | Award Year | Award Amount, USD | | 1P01CA083155-01 | 1999 | $543,866 | | 5P01CA083155-02 | 2000 | $1,039,240 | | 5P01CA083155-03 | 2001 | $1,070,422 | | 5P01CA083155-04 | 2002 | $1,188,073 | | 5P01CA083155-05 | 2003 | $422,655 | | 7P01CA083155-06 | 2003 | $884,259 | | Total up to 2004 | $5,148,515 |
- BIOSYNTHETIC ANALYSIS OF MARINE CYANOBACTERIAL PATHWAYS (SHERMAN, DAVID - 2006)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- LASER SPECKLE IMAGING OF BRAIN TUMOR VASCULATURE (SHERMAN, DAVID - 2008)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- MOLECULAR GENETICS OF POLYKETIDE & FATTY ACID SYNTHASES (SHERMAN, DAVID - 1992)
| Grant # | Award Year | Award Amount, USD | | 1R01GM046884-01 | 1992 | $129,031 | | 3R01GM046884-02S1 | 1993 | $4,487 | | 5R01GM046884-02 | 1993 | $122,752 | | 5R01GM046884-03 | 1994 | $127,663 | | 5R01GM046884-04 | 1995 | $175,730 | | Total up to 2004 | $559,663 |
- MOLECULAR GENETIC STUDIES OF METHYMYCIN BIOSYNTHESIS (SHERMAN, DAVID - 1993)
| Grant # | Award Year | Award Amount, USD | | 1R01GM048562-01 | 1993 | $93,282 | | 3R01GM048562-01S1 | 1994 | $14,020 | | 5R01GM048562-02 | 1994 | $178,881 | | 5R01GM048562-03 | 1995 | $171,821 | | 5R01GM048562-04 | 1996 | $162,608 | | 2R01GM048562-05 | 1999 | $370,386 | | 5R01GM048562-06 | 2000 | $381,323 | | 5R01GM048562-07 | 2001 | $392,588 | | 5R01GM048562-08 | 2002 | $404,193 | | Total up to 2004 | $2,169,102 |
- METABOLIC ENGINEERING OF CEPHAMYCIN C BIOSYNTHESIS (SHERMAN, DAVID - 1997)
| Grant # | Award Year | Award Amount, USD | | 1R01GM055850-01 | 1997 | $170,055 | | 5R01GM055850-03 | 1999 | $179,920 | | 5R01GM055850-04 | 2000 | $184,349 | | 2R01GM055850-05A1 | 2002 | $289,560 | | 5R01GM055850-06 | 2003 | $85,188 | | 7R01GM055850-07 | 2003 | $203,051 | | 5R01GM055850-08 | 2004 | $289,631 | | Total up to 2004 | $1,401,754 |
- MOLECULAR ANALYSIS OF MODULAR POLYKETIDE SYNTHASES (SHERMAN, DAVID - 2006)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- STRUCTURE AND ENGINEERING OF NATURAL PRODUCT CYTOCHROME P450 ENZYMES (SHERMAN, DAVID - 2007)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- PERINATAL VITAL SIGNS MONITOR (SHERMAN, DAVID - 1999)
| Grant # | Award Year | Award Amount, USD | | 1R43HD037332-01 | 1999 | $100,000 | | Total up to 2004 | $100,000 |
- QEP ANALYSIS OF COMATOSE PATIENTS: MUTAL SYNCHRONICITY (SHERMAN, DAVID - 2004)
| Grant # | Award Year | Award Amount, USD | | 1R43HL076991-01 | 2004 | $184,972 | | Total up to 2004 | $184,972 |
- <TITLE UNKNOWN> (SHERMAN, DAVID A - 1999)
| Grant # | Award Year | Award Amount, USD | | 1F31MH012492-01 | 1999 | $29,471 | | Total up to 2004 | $29,471 |
- TRACING SEIZURE PATHWAYS USING QUANTITATIVE EEG (SHERMAN, DAVID - 1999)
| Grant # | Award Year | Award Amount, USD | | 1R01NS035528-01A2 | 1999 | $181,936 | | 5R01NS035528-02 | 2000 | $162,601 | | 3R01NS035528-02S1 | 2001 | $44,963 | | 5R01NS035528-03 | 2001 | $208,457 | | 5R01NS035528-04 | 2002 | $168,397 | | Total up to 2004 | $766,354 |
- NEONATAL CORTICAL INJURY MONITOR (SHERMAN, DAVID - 1998)
| Grant # | Award Year | Award Amount, USD | | 1R43NS038016-01 | 1998 | $100,000 | | Total up to 2004 | $100,000 |
- AUTOMATED SEIZURE DETECTION FOLLOWING NERVE AGENT EXPOSURE (SHERMAN, DAVID - 2006)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- SURFACE MYOELECTRIC CONTROL OF HAND PROTHETICS (SHERMAN, DAVID - 2008)
| Grant # | Award Year | Award Amount, USD | | award information is not available | | Total up to 2004 | $NA |
- INTRAOPERATIVE NEUROLOGICAL MONITOR (SHERMAN, DAVID - 1998)
| Grant # | Award Year | Award Amount, USD | | 1N43NS082397-000 | 1998 | $99,999 | | Total up to 2004 | $99,999 |
David R Sherman Articles (7) [selected PubMed articles for the year 2004 with the links to a full text at PubMed]Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant. (2004) >> Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USA. 1Clay, Hilary, 1Beery, Dana, 1Chang, Jennifer C W, 1Volkman, Hannah E, 3Ramakrishnan, Lalita, 7Sherman, David R.Mycobacterium tuberculosis H37Rv: Delta RD1 is more virulent than M. bovis bacille Calmette-Guérin in long-term murine infection. (2004) >> Department of Pathobiology, University of Washington, Seattle 98195-7238, USA. 2Guinn, Kristi M, 3Hickey, Mark J, 3Smith, Sherilyn, 2Mathur, Sanjeev K, 7Sherman, David R, 2Zakel, Kelly L.Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. (2004) >> Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington 98195, USA. 21Hol, Wim G J, 3Roberts, David M, 1Liao, Reiling P, 7Sherman, David R, 4Wisedchaisri, Goragot.Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines. (2004) >> Centre for the Study of Host Resistance, McGill University, Montreal H3G 1A4, Canada. 1Di Pietrantonio, Tania, 5Schurr, Erwin, 1Belley, Adam, 5Alexander, David, 9Behr, Marcel A, 64Liu, Jun, 1Girard, Manon, 1Jones, Joses, 7Sherman, David R.Adenylylation and catalytic properties of Mycobacterium tuberculosis glutamine synthetase expressed in Escherichia coli versus mycobacteria. (2004) >> Departments of Pathobiology and Medicinal Chemistry, University of Washington, Seattle, Washington 98195-7610, USA. 2Mehta, Ranjana, 3Hickey, Mark J, 1Mahajan, Sumit, 1Pearson, Josh T, 4Atkins, William M, 1Nath, Abhinav, 7Sherman, David R.Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. (2004) >> Department of Pathobiology, University of Washington, Seattle, WA 98195, USA. 2Guinn, Kristi M, 3Hickey, Mark J, 3Smith, Sherilyn, 2Mathur, Sanjeev K, 1Grotzke, Jeff E, 5Lewinsohn, David M, 7Sherman, David R, 2Zakel, Kelly L.The Mycobacterium tuberculosis complex transcriptome of attenuation. (2004) >> McGill University Health Centre, Montreal, Canada H3G 1A4. 6Mostowy, Serge, 9Behr, Marcel A, 7Sherman, David R, 2Cleto, Cynthia.
Science Trivia (2) [Interactive math & science trivia questions]
|
|